Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies
CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — SP+® Corporation (SP+), (Nasdaq: SP) a best-in-class technology and operations management provider of […]
GCM Grosvenor to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Conference Call on February 13, 2024
CHICAGO, Jan. 30, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today […]
Douglas Dynamics Announces Preliminary Fourth Quarter and Full Year 2023 Results and Implementation of 2024 Cost Savings Program
Work Truck Attachments – Ongoing lack of snowfall significantly impacted fourth quarter results Work Truck Solutions – Produced Net Sales […]
Western Uranium & Vanadium Bolsters Mining Team to Scale-Up Uranium Production
Toronto, Ontario and Nucla, Colorado, Jan. 30, 2024 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) […]
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated […]
RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform
LAKEWOOD, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance” or the “Company”), today […]
CorMedix Inc. Announces Commercial and Reimbursement Updates
BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics […]
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a […]
Freedom of Mobility Forum Announces 2024 Topic, Expert Panelists and University Participants for Second Annual Live Debate on April 3
Freedom of Mobility Forum Announces 2024 Topic, Expert Panelists and University Participants for Second Annual Live Debate on April 3 […]
